NANTONG, JIANGSU, CHINA, January 20, 2026 /EINPresswire.com/ -- As global demand for advanced filtration solutions ...

Seeking to ramp up the nation’s capacity to administer a possible COVID-19 vaccine, the Trump administration has signed a $138 million deal with the makers of an innovative syringe designed to be used ...

BD (NYSE:BDX) announced Thursday that the company has increased its domestic manufacturing of syringes after the FDA warned about quality issues linked to plastic syringes made in China. Since the FDA ...

FRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its ...

Lest this week’s news about FDA cautioning against the use of plastic syringes made in China raise concerns of a possible shortage, BD announced today that it is increasing its US production of ...

BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the US. The company aims to strengthen the pharmaceutical supply chain and ...

The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...

Sharps Technology Inc., a publicly traded medical device company, has plans to acquire the first fully dedicated specialized polymer syringe manufacturing plant in North America, and has been ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...